Cargando…
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
Cytokine storm can result from cancer immunotherapy or certain infections, including COVID-19. Though short-term immune-related adverse events are routinely described, longer-term immune consequences and sequential immune monitoring are not as well defined. In 2006, six healthy volunteers received T...
Autores principales: | Panoskaltsis, Nicki, McCarthy, Neil E., Stagg, Andrew J., Mummery, Catherine J., Husni, Mariwan, Arebi, Naila, Greenstein, David, Price, Claire L., Al-Hassi, Hafid O., Koutinas, Michalis, Mantalaris, Athanasios, Knight, Stella C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543968/ https://www.ncbi.nlm.nih.gov/pubmed/33033851 http://dx.doi.org/10.1007/s00262-020-02725-2 |
Ejemplares similares
-
Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing αβ and γδT cells
por: McCarthy, Neil E., et al.
Publicado: (2020) -
TGN1412: From Discovery to Disaster
por: Attarwala, H
Publicado: (2010) -
Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release
por: Eastwood, David, et al.
Publicado: (2013) -
After TGN1412: Recent developments in cytokine release assays
por: Stebbings, R., et al.
Publicado: (2013) -
Revisiting CD28 Superagonist TGN1412 as Potential Therapeutic for Pediatric B Cell Leukemia: A Review
por: Brown, Katelyn E.
Publicado: (2018)